Venetoclax For Multiple Myeloma

HealthTree University: Therapies On The Horizon - Venetoclax

Learn about Venetoclax, a promising drug for the treatment of B cell malignancies, including lymphomas and multiple myeloma. This drug specifically targets the anti-apoptotic protein BCL-2. Watch the video below for more information on its administration and success rates in clinical trials, including in combination with other drugs like dexamethasone and bortezomib. Don't miss out on this exciting new development in cancer treatment! HealthTree University.

Venetoclax

We’d like to thank our faculty who donated their time in creating these videos, including:

• Ariel Grajales-Cruz, MD

Want more?

We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

• Myeloma Basics Part 1
• Myeloma Basics Part 2
• Myeloma Basics Part 3
• Myeloma Care Basics
• Building Your Healthcare Team
• Becoming an Empowered Patient
• Starting Myeloma Treatment
• Know Your Therapy
• Know Your Labs: Blood and Urine Testing in Myeloma
• Autologous Stem Cell Transplant (ASCT)
• Precursor Conditions
• Relapsed and Refractory MM Treatment
• Classes of Drugs
• Immunotherapy
• Myeloma Bone Disease
• Imaging in Myeloma
• MRD Testing
• Basic Genetics and Cancer Biology
• Myeloma Genetics
• Types of Genetic Testing in Myeloma
• Specific Myeloma Genetics Mutations and Risk
• Precision Medicine
• Financial Advice for Myeloma Patients and Their Families
• Geriatric Care and Myeloma
• Myeloma Kidney Disease
• Amyloidosis
• Myeloma Basics (Spanish)
• COVID-19 and Multiple Myeloma
• Complementary and Integrated Therapy
• Allogeneic Stem Cell Transplant
• Survivorship
• Clinical Trials
• Understanding Basic Blood tests
• Myeloma Vaccines